Merger Synergy Interview Mastery
This conversation was generated using Cook'd AI's career assistant and reviewed by Fallon Han from our editorial team for accuracy.
I'm a third-year commerce student applying for corporate development roles at a large healthcare company in Sydney. I have a temporary graduate visa, so I want to sound practical and credible. In a merger synergies question, how do I explain where synergies come from and why they might not be achievable?
Start by splitting synergies into clear buckets, then link each one to real integration work. In healthcare, the main sources are usually cost synergies, revenue synergies, and financing or tax benefits.
For cost synergies, talk about overlapping corporate functions, procurement savings, shared IT, and better use of facilities or admin teams. For revenue synergies, mention cross-referrals, broader patient networks, or a stronger product and service offering, but be careful because these are usually harder to capture.
Then explain why synergies may not be achievable. The biggest reasons are integration risk, culture clash, regulatory approvals, systems incompatibility, and customer or clinician disruption. In healthcare specifically, service continuity and compliance matter a lot, so even a good synergy case can fall apart if integration creates operational risk.
A strong answer sounds like this: the value is real, but only if management can execute the integration cleanly and on time.
How should I make that sound more like a corporate development answer, not just a generic M&A answer?
Use a value-creation lens, not just a list of synergies. Corporate development teams care about what can be underwritten, when it can be realized, and how much risk sits behind it.
A good structure is:
1. What synergies are available
2. How large they are and how fast they can be achieved
3. What could block them
4. How you would test them in diligence
For example, you could say: 'In a healthcare merger, the biggest value usually comes from cost synergies in back-office functions and procurement. Revenue synergies are possible, but I would treat them conservatively because they depend on patient flow, clinician adoption, and regulatory constraints. I would also discount synergies that require major system integration or workforce changes, because those are the most likely to slip.'
That sounds more like someone who is thinking about deal certainty, not just theory.
If they push me on integration risks, what are the most realistic ones I should mention for a large healthcare company in Sydney?
Focus on risks that are practical and specific.
The best ones are:
- IT and data migration risk, especially with patient records and billing systems
- Compliance and regulatory risk, because healthcare has strict standards
- Workforce retention risk, since clinical and support staff may leave after a merger
- Operational disruption, which can affect patient care and service levels
- Cultural mismatch between teams, especially if one business is more clinical and the other more corporate
If you want to sound sharp, connect each risk to the impact on synergies. For example, if the merged company cannot migrate systems smoothly, it may fail to achieve procurement savings or centralized admin benefits on time. If staff leave, planned productivity gains may never show up.
That shows you understand that synergies are not just an accounting exercise. They depend on execution.
How do I explain why some synergies are more achievable than others?
Say that the most achievable synergies are usually the ones with low operational complexity and clear ownership.
For example, corporate overhead savings, vendor consolidation, and procurement are more achievable because they are easier to identify, measure, and implement. You know who owns them, and the impact is usually visible fairly quickly.
By contrast, revenue synergies are less certain because they depend on behavior changes, such as doctors referring more patients, customers adopting new services, or different teams selling together. Those outcomes are harder to control.
A strong line would be: 'I would be more confident underwriting cost synergies that come from eliminating duplicate functions than revenue synergies that depend on cross-selling, because the former are directly controllable while the latter depend on market and human behavior.'
That is a very credible interview answer.
Can you help me turn this into a short 60-second answer I can memorize?
Yes. Try this:
'In a merger, synergies usually come from three places: cost savings, revenue opportunities, and sometimes financing or tax benefits. In a healthcare deal, the most reliable synergies are usually cost-related, such as consolidating corporate functions, procurement, and some shared services. Revenue synergies can exist, like cross-referrals or expanding service offerings, but I would be more conservative on those because they are harder to achieve and depend on integration quality.
The main reason synergies may not be realized is execution risk. In healthcare, that includes IT migration, compliance issues, staff retention, and disruption to patient services. So in diligence, I would focus on how realistic the synergy case is, how quickly it can be captured, and what integration work is required. My view is that synergies create real value, but only if they are operationally achievable and not just financial assumptions on a slide.'
If you want, I can also help you make that sound more confident and less scripted.